Our Intellectual Property (IP) rights cover most important pharmaceuticals markets globally.
We own 19 issued patents, and pursue multiple patent continuations, active prosecutions and divisional applications on a global scale.
CA2922099
CA2941632
MX376522
– (MX2016002502)
MX382476
– (MX2016011236)
MX395456
– (MX2020006075 )
JP6571657
JP6883428
CN105491886
AU2014311570
AU2015229842
ZA201601645
ZA201606849
© Exinda Therapeutics LLC, 2024. All Rights Reserved.